Elucidation of the relationship of BNIP3 expression to gemcitabine chemosensitivity and prognosis

doi:10.3748/wjg.v13.i34.4593

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 34

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2929)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

351

HTML

2174

Figures (1-4)

262

Tables (1-1)

142

Sum=2929

Sep 14, 2007 (publication date) through Jul 25, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Sep 14, 2007; 13(34): 4593-4597
Published online Sep 14, 2007. doi: 10.3748/wjg.v13.i34.4593

Full Size Figure Download Figure

Figure 3 Immunohistochemical analysis of BNIP3 in primary pancreatic cancer specimens. A monoclonal anti-BNIP3 antibody (clone Ana 40) was used. A: Punctate perinuclear staining; B: Diffuse cytoplasmic staining; C: Negative/faint staining.

Citation: Ishida M, Sunamura M, Furukawa T, Akada M, Fujimura H, Shibuya E, Egawa S, Unno M, Horii A. Elucidation of the relationship of BNIP3 expression to gemcitabine chemosensitivity and prognosis. World J Gastroenterol 2007; 13(34): 4593-4597
URL: https://www.wjgnet.com/1007-9327/full/v13/i34/4593.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i34.4593